Expression of the genes for lysostaphin and lysostaphin resistance in streptococci

FEMS Microbiology Letters

Volumn 228, Issue 1, 2003, Pages 115-119

  Farris, M Heath ^a   Heath, Lucie S ^a   Heath, Harry E ^a   LeBlanc, Paul A ^a   Simmonds, Robin S ^b   Sloan, Gary L ^a  

^a UNIVERSITY OF ALABAMA   (United States)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Lysostaphin; Peptidoglycan hydrolase; Staphylococcus simulans biovar staphylolyticus; Streptococcus equi subsp. zooepidemicus; Zoocin A

Indexed keywords

LYSOSTAPHIN; PEPTIDOGLYCAN; PROTEINASE; SERINE;

AMINO ACID ANALYSIS; ARTICLE; BACTERIAL STRAIN; DNA ISOLATION; ENZYME SYNTHESIS; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE TRANSFER; LYSIS; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STAPHYLOCOCCUS SIMULANS; STREPTOCOCCUS EQUI; STREPTOCOCCUS EQUI ZOOEPIDEMICUS;

INSERTION SEQUENCES; STAPHYLOCOCCUS; STAPHYLOCOCCUS SIMULANS; STREPTOCOCCUS; STREPTOCOCCUS EQUI; STREPTOCOCCUS EQUI SUBSP. ZOOEPIDEMICUS;

EID: 0242721752     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(03)00743-2     Document Type: Article

References (21)

1. Sloan G.L., Robinson J.M., Kloos W.E. Identification of 'Staphylococcus staphylolyticus' NRRL B-2628 as a biovar of Staphylococcus simulans. Int. J. Syst. Bacteriol. 32:1982;170-174.
2. Heath L.S., Heath H.E., Sloan G.L. Plasmid-encoded lysostaphin endopeptidase gene of Staphylococcus simulans biovar staphylolyticus. FEMS Microbiol. Lett. 44:1987;129-133.
3. Browder H.P., Zygmunt W.A., Young J.R., Tavormina P.A. Lysostaphin: enzymatic mode of action. Biochem. Biophys. Res. Commun. 19:1965;383-389.
4. Simmonds R.S., Naidoo J., Jones C.L., Tagg J.R. The streptococcal bacteriocin-like inhibitory substance, zoocin A, reduces the proportion of Streptococcus mutans in an artificial plaque. Microb. Ecol. Health Dis. 8:1995;281-292.
5. Simmonds R.S., Simpson W.J., Tagg J.R. Cloning and sequence analysis of zooA, a Streptococcus zooepidemicus gene encoding a bacteriocin-like inhibitory substance having a domain structure similar to that of lysostaphin. Gene. 189:1997;255-261.
6. Lai A.C.-Y., Tran S., Simmonds R.S. Functional characterization of domains found within a lytic enzyme produced by Streptococcus equi subsp. zooepidemicus. FEMS Microbiol. Lett. 215:2002;133-138.
7. Thumm G., Götz F. Studies on prolysostaphin processing and characterization of the lysostaphin immunity factor (Lif) of Staphylococcus simulans biovar staphylolyticus. Mol. Microbiol. 23:1997;1251-1265.
8. Beatson S.A., Sloan G.L., Simmonds R.S. Zoocin A immunity factor: a femA-like gene found in a group C streptococcus. FEMS Microbiol. Lett. 163:1998;73-77.
9. Heath H.E., Heath L.S., Nitterauer J.D., Rose K.E., Sloan G.L. Plasmid-encoded lysostaphin endopeptidase resistance of Staphylococcus simulans biovar staphylolyticus. Biochem. Biophys. Res. Commun. 160:1989;1106-1109.
10. DeHart H.P., Heath H.E., Heath L.S., LeBlanc P.A., Sloan G.L. The lysostaphin endopeptidase resistance gene (epr) specifies modification of peptidoglycan cross bridges in Staphylococcus simulans and Staphylococcus aureus. Appl. Environ. Microbiol. 61:1995;1475-1479.
11. Rohrer S., Berger-Bächi B. FemABX peptidyl transferases: a link between branched-chain cell wall peptide formation and β-lactam resistance in gram-positive cocci. Antimicrob. Agents Chemother. 47:2003;837-846.
12. Maidhof H., Reinicke B., Blümel P., Berger-Bächi B., Labischinski H. femA, which encodes a factor essential for expression of methicillin resistance, affects glycine content of peptidoglycan in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains. J. Bacteriol. 173:1991;3507-3513.
13. Ehlert K., Schröder W., Labischinski H. Specificities of FemA and FemB for different glycine residues: FemB cannot substitute for FemA in staphylococcal peptidoglycan pentaglycine side chain formation. J. Bacteriol. 179:1997;7573-7576.
14. Ehlert K., Tschierske M., Mori C., Schröder W., Berger-Bächi B. Site-specific serine incorporation by Lif and Epr into positions 3 and 5 of the staphylococcal peptidoglycan interpeptide bridge. J. Bacteriol. 182:2000;2635-2638.
15. Macrina F.L., Tobian J.A., Jones K.R., Evans R.P., Clewell D.B. A cloning vector able to replicate in Escherichia coli and Streptococcus sanguis. Gene. 19:1982;345-353.
16. Schindler C.A., Schuhardt V.T. Lysostaphin: a new bacteriolytic agent for the Staphylococcus. Proc. Natl. Acad. Sci. USA. 51:1964;414-421.
17. Macrina F.L., Keeler C.L., Jones K.R., Wood P.H. Molecular characterization of unique deletion mutants of the streptococcal plasmid pAMβ1. Plasmid. 4:1980;8-16.
18. Buckley N.D., Vadeboncoeur C., LeBlanc D.J., Lee L.N., Frenette M. An effective strategy, applicable to Streptococcus salivarius and related bacteria, to enhance or confer electroporation competence. Appl. Environ. Microbiol. 65:1999;3800-3804.
19. Neumann V.C., Heath H.E., LeBlanc P.A., Sloan G.L. Extracellular proteolytic activation of bacterial peptidoglycan hydrolases of Staphylococcus simulans biovar staphylolyticus. FEMS Microbiol. Lett. 110:1993;205-212.
20. Zhou R., Chen S., Recsei P. A dye release assay for determination of lysostaphin activity. Anal. Biochem. 171:1988;141-144.
21. Bunn W.J., Heath H.E., LeBlanc P.A., Sloan G.L. Wall-associated processing of extracellular enzymes of Staphylococcus simulans biovar staphylolyticus. FEMS Microbiol. Lett. 165:1998;123-127.